Bio-Rad Laboratories
Price & Volume
Stats
See moreOpen | $377.84 |
Previous Close | $380.03 |
Day Range | $374.16-$382.10 |
52W Range | $236.73-$385.92 |
Market Cap | $10.1B |
Shares Short | 2 |
Financials
See moreRevenue (12 Mos) | $2.5B |
Revenue Growth (YoY) | -0.1% |
Gross Profit (12 Mos) | $1.3B |
Diluted EPS | $8.21 |
News
See moreYahoo Finance • 13 days ago
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
Yahoo Finance • 14 days ago
Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific
Yahoo Finance • 20 days ago
Bio-Rad forecasts 2026 currency-neutral revenue growth of (-3%) to +0.5% while targeting $30M-$35M net cost savings by end of 2027
Yahoo Finance • 20 days ago
SR Inc Net Zero Consortium for Buyers: Seven-Buyer Aggregation for 180 MW of Millers Branch Solar Now Online
About
CEO | Mr. Norman D. Schwartz |
CFO | Mr. Roop K. Lakkaraju CPA |
Address | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 7,450 |